Cardio 3 Biosciences - Press releases (by year)

News & event

Press releases (by year)

Glossary

Press releases (by year)

Attention, ouverture dans une nouvelle fenêtre.

2010

Cardio3 BioSciences Publishes the Science Basis for C-Cure® in JACC FR NL

Cardio3 BioSciences Reports Positive Three-Month Data from its Clinical Trial of C-Cure® in Heart Failure FR NL

Cardio3 BioSciences Announces Promising Pre‐Clinical Data for Proprietary C‐Cath® Catheter FR NL

2009

Cardio3 BioSciences at ESC Barcelona

Cardio3 BioSciences To Present At Forthcoming BioEquity Europe 2009 Meeting

Cardio3 BioSciences at EuroPCR Barcelona

Cardio3 BioSciences Treats Its First Patient with C-Cure®, a Second-Generation Stem Cell Derived Therapy for Heart Failure

Cardio3 BioSciences Raises €13.7 million in Series B Fundraising and Grant Funding

2008

Cardio3 BioSciences receives its accreditation number from the Belgian Federal Agency for Medicines and Health Products for the manufacture of C-Cure™ for human use.

Cardio3 BioSciences SA signs a co-development agreement with Artelis SA for the industrialization of the manufacturing process of C-Cure™ and inaugurate its new premises in Mont-Saint-Guibert

IR Contact

© 2009 Cardio 3 Biosciences

A concept of Expansion